Swiss Re’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-322,230
Closed -$41.7M 8
2023
Q1
$41.7M Hold
322,230
9.79% 6
2022
Q4
$43.8M Hold
322,230
8.01% 7
2022
Q3
$39M Sell
322,230
-815,700
-72% -$105M 11.4% 6
2022
Q2
$146M Sell
1,137,930
-462,070
-29% -$60.6M 29.2% 1
2022
Q1
$219M Hold
1,600,000
38.54% 1
2021
Q4
$225M Buy
1,600,000
+792,000
+98% +$105M 45.44% 1
2021
Q3
$103M Hold
808,000
26.61% 2
2021
Q2
$102M Buy
+808,000
New +$99M 34.82% 2

Other funds holding XLV

Swiss Re's XLV Position: Q2 2023 in Review

Swiss Re sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q2 2023, closing a stake of 322,230 shares — an estimated $41.7M sold.

Swiss Re first reported a position in XLV in Q2 2021 and held it in 8 quarters. The position peaked at $225M in Q4 2021. 1,542 funds tracked by Wall St. Rank hold XLV as of Q2 2023.

  • Swiss Re reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q2 2023 after selling out during the quarter.
  • Swiss Re sold 322,230 State Street Health Care Select Sector SPDR ETF shares in Q2 2023, an estimated $41.7M.
  • Swiss Re first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2021 and held it in 8 quarters.
  • Swiss Re's State Street Health Care Select Sector SPDR ETF position peaked at $225M in Q4 2021.
  • 1,542 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2023.

Based on Swiss Re's 13F filing for Q2 2023, filed 9 Aug 2023.